Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Ophthalmological Medicine
Volume 2016, Article ID 4756894, 5 pages
http://dx.doi.org/10.1155/2016/4756894
Case Report

Pseudotumor Cerebri in a Child with Idiopathic Growth Hormone Insufficiency Two Months after Initiation of Recombinant Human Growth Hormone Treatment

1Department of Ophthalmology, Makarios Hospital, 2012 Nicosia, Cyprus
21st University Eye Clinic, 11527 Athens, Greece

Received 24 November 2015; Revised 17 January 2016; Accepted 20 January 2016

Academic Editor: Ruth Huna-Baron

Copyright © 2016 Eleni Loukianou et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Malozowski, L. A. Tanner, D. Wysowski, and C. A. Fleming, “Growth hormone, insulin-like growth factor I, and benign intracranial hypertension,” The New England Journal of Medicine, vol. 329, no. 9, pp. 665–666, 1993. View at Publisher · View at Google Scholar · View at Scopus
  2. S. Dhungana, B. Sharrack, and N. Woodroofe, “Idiopathic intracranial hypertension,” Acta Neurologica Scandinavica, vol. 121, no. 2, pp. 71–82, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Wall, J. J. Corbett, D. I. Friedman, G. Liu, and K. Digre, “Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children,” Neurology, vol. 83, no. 2, pp. 198–200, 2014. View at Publisher · View at Google Scholar
  4. P. Babikian, J. Corbett, and W. Bell, “Idiopathic intracranial hypertension in children: the Iowa experience,” Journal of Child Neurology, vol. 9, no. 2, pp. 144–149, 1994. View at Publisher · View at Google Scholar · View at Scopus
  5. L. M. Rangwala and G. T. Liu, “Pediatric idiopathic intracranial hypertension,” Survey of Ophthalmology, vol. 52, no. 6, pp. 597–617, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Lessell, “Pediatric pseudotumor cerebri (idiopathic intracranial hypertension),” Survey of Ophthalmology, vol. 37, no. 3, pp. 155–166, 1992. View at Publisher · View at Google Scholar · View at Scopus
  7. P. H. Phillips, M. X. Repka, and S. R. Lambert, “Pseudotumor cerebri in children,” Journal of AAPOS, vol. 2, no. 1, pp. 33–38, 1998. View at Publisher · View at Google Scholar · View at Scopus
  8. A. H. Rogers, G. L. Rogers, D. L. Bremer, and M. L. McGregor, “Pseudotumor cerebri in children receiving recombinant human growth hormone,” Ophthalmology, vol. 106, no. 6, pp. 1186–1190, 1999. View at Publisher · View at Google Scholar · View at Scopus
  9. G. Tornese, G. Tonini, F. Patarino, F. Parentin, and F. Marchetti, “Double adverse drug reaction: recombinant human growth hormone and idiopathic intracranial hypertension—acetazolamide and metabolic acidosis: a case report,” Cases Journal, vol. 2, article 6534, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. G. D. Reeves and D. A. Doyle, “Growth hormone treatment and pseudotumor cerebri: coincidence or close relationship?” Journal of Pediatric Endocrinology and Metabolism, vol. 15, supplement 2, pp. 723–730, 2002. View at Google Scholar · View at Scopus
  11. P. E. Clayton and C. T. Cowell, “Safety issues in children and adolescents during growth hormone therapy—a review,” Growth Hormone and IGF Research, vol. 10, no. 6, pp. 306–317, 2000. View at Publisher · View at Google Scholar · View at Scopus
  12. L. Frisen, “Swelling of the optic nerve head: a staging scheme,” Journal of Neurology, Neurosurgery & Psychiatry, vol. 45, no. 1, pp. 13–18, 1982. View at Publisher · View at Google Scholar · View at Scopus
  13. B. J. Otten, J. J. Roettvel, and J. R. M. Cruysberg, “Pseudotumor cerebri following treatment with growth hormone,” Hormone Research, vol. 37, p. 16, 1992. View at Google Scholar
  14. S. Bechtold, O. Butenandt, A. Meidert, H. Schmidt, and K.-P. Boergen, “Persistent papilledema in Ullrich-Turner syndrome treated with growth hormone,” Clinical Pediatrics, vol. 40, no. 11, pp. 629–631, 2001. View at Publisher · View at Google Scholar · View at Scopus
  15. F. Distelmaier, U. Sengler, M. Messing-Juenger, B. Assmann, E. Mayatepek, and T. Rosenbaum, “Pseudotumor cerebri as an important differential diagnosis of papilledema in children,” Brain and Development, vol. 28, no. 3, pp. 190–195, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. I. Francois, I. Casteels, J. Silberstein, P. Casaer, and F. De Zegher, “Empty sella, growth hormone deficiency and pseudotumour cerebri: effect of initiation, withdrawal and resumption of growth hormone therapy,” European Journal of Pediatrics, vol. 156, no. 1, pp. 69–70, 1997. View at Publisher · View at Google Scholar · View at Scopus
  17. P. A. Crock, J. D. McKenzie, A. M. Nicoll et al., “Benign intracranial hypertension and recombinant growth hormone therapy in Australia and New Zealand,” Acta Paediatrica, vol. 87, no. 4, pp. 381–386, 1998. View at Publisher · View at Google Scholar · View at Scopus
  18. E. A. Koller, B. V. Stadel, and S. N. Malozowski, “Papilledema in 15 renally compromised patients treated with growth hormone,” Pediatric Nephrology, vol. 11, no. 4, pp. 451–454, 1997. View at Publisher · View at Google Scholar · View at Scopus
  19. D. A. Price, P. E. Clayton, and I. C. Lloyd, “Benign intracranial hypertension induced by growth hormone treatment,” The Lancet, vol. 345, no. 8947, pp. 458–459, 1995. View at Publisher · View at Google Scholar · View at Scopus